Uncovering the Truth: Kaplan Fox Kilsheimer LLP Launches Investigation into Eagle Pharmaceuticals Inc. (NASDAQ: EGRX)

Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) The Investigation NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased securities of Woodcliff Lake, New Jersey-based Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”). If you purchased Eagle…

Read More

Attention Shareholders: Levi & Korsinsky Notifies Investors of Class Action Lawsuit and Upcoming Deadline for The Beauty Health Company (SKIN)

SHAREHOLDER ALERT: Levi & Korsinsky Notifies The Beauty Health Company Investors of a Class Action Lawsuit New York, Nov. 29, 2023 (GLOBE NEWSWIRE) Overview Levi & Korsinsky, LLP, a leading securities litigation firm, has announced that it is notifying investors in The Beauty Health Company (NASDAQ: SKIN) about a class action securities lawsuit. The lawsuit…

Read More

Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein Gewirtz & Grossman LLC to Claim Your Losses

Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC New York, Nov. 29, 2023 (GLOBE NEWSWIRE) — Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is currently investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“Schultze”), which completed a merger with…

Read More

Uncovering Potential Breaches of Fiduciary Duty: Investigating Orthofix Medical Inc. (NASDAQ: OFIX) by Lowey Dannenberg P.C.

Lowey Dannenberg, P.C. Investigating Potential Breach of Fiduciary Duty at Orthofix Medical Inc. New York, Nov. 29, 2023 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a leading law firm known for seeking justice for consumers and investors, is currently looking into a potential breach of fiduciary duty claim involving the board of directors of Orthofix Medical…

Read More